Literature DB >> 8105251

Vitamin B12 deficiency in adolescents and young adults with phenylketonuria.

W B Hanley, A Feigenbaum, J T Clarke, W Schoonheyt, V Austin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8105251     DOI： 10.1016/0140-6736(93)92047-w

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Nutritional Consequences of Adhering to a Low Phenylalanine Diet for Late-Treated Adults with PKU : Low Phe Diet for Adults with PKU.

Authors:  Ingrid Wiig; Kristina Motzfeldt; Elin Bjørge Løken; Bengt Frode Kase
Journal:  JIMD Rep       Date:  2012-07-01

2.  Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.

Authors:  S Yannicelli; D M Medeiros
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

Review 3.  Late effects of phenylketonuria.

Authors:  J H Walter
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

4.  Normal serum levels of vitamin B12 and folic acid in children with phenylketonuria.

Authors:  P Strisciuglio; D Concolino; M T Moricca; L Rivalta; G Parlato
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

5.  Vitamin B12 and vitamin B6 supplementation is needed among adults with phenylketonuria (PKU).

Authors:  A M Hvas; E Nexo; J B Nielsen
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

6.  Phenylketonuria: treatment in adolescence and adult life.

Authors:  D P Brenton; A C Tarn; J C Cabrera-Abreu; M Lilburn
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 7.  The truth of treating patients with phenylketonuria after childhood: the need for a new guideline.

Authors:  F J van Spronsen; P Burgard
Journal:  J Inherit Metab Dis       Date:  2008-08-12       Impact factor: 4.982

Review 8.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

9.  PKU-what is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied Disorders.

Authors:  F J van Spronsen; K Kiaer Ahring; M Gizewska
Journal:  J Inherit Metab Dis       Date:  2009-01-13       Impact factor: 4.982

Review 10.  Mild hyperphenylalaninemia: to treat or not to treat.

Authors:  Francjan J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2011-02-24       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.